Ceftolozane-tazobactam versus levofloxacin in urinary tract infection

被引：5
|
作者：
Popa, Ciprian [1 ]
Mircheva, Miryana [1 ]
Kraemer, Bernhard K. [1 ]
Berghofen, Andrea [1 ]
Krueger, Bernd [1 ]
机构：
[1] Heidelberg Univ, Univ Med Mannheim, D-68167 Mannheim, BW, Germany
来源：
LANCET | 2015年 / 386卷 / 10000期
关键词：
D O I：
10.1016/S0140-6736(15)00262-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1241 / 1242
页数：2
相关论文
共 50 条
  • [31] Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
    Barnes, Melissa D.
    Taracila, Magdalena A.
    Rutter, Joseph D.
    Bethel, Christopher R.
    Galdadas, Ioannis
    Hujer, Andrea M.
    Caselli, Emilia
    Prati, Fabio
    Dekker, John P.
    Papp-Wallace, Krisztina M.
    Haider, Shozeb
    Bonomo, Robert A.
    MBIO, 2018, 9 (06):
  • [32] Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections
    Bassetti, Matteo
    Righi, Elda
    FUTURE MICROBIOLOGY, 2015, 10 (02) : 151 - 160
  • [33] Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
    Scott, Lesley J.
    DRUGS, 2016, 76 (02) : 231 - 242
  • [34] Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria
    Chen, Guan-Jhou
    Pan, Sung-Ching
    Foo, Jason
    Morel, Chaienna
    Chen, Wei-Ting
    Wang, Jann-Tay
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (05) : 807 - 815
  • [35] Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation
    Amore, Davide
    Pecoraro, Ylenia
    Carillo, Carolina
    Russo, Gianluca
    Poggi, Camilla
    Anile, Marco
    Pagini, Andreina
    Bassi, Massimiliano
    Cagnetti, Sara
    Mottola, Emilia
    D'Agostino, Federica Gilda
    Vannucci, Jacopo
    Mantovani, Sara
    Pugliese, Francesco
    De Giacomo, Tiziano
    Rendina, Erino Angelo
    Venuta, Federico
    Diso, Daniele
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (05) : 1605 - 1607
  • [36] Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
    Lesley J. Scott
    Drugs, 2016, 76 : 231 - 242
  • [37] Use of ceftolozane-tazobactam in a cystic fibrosis patient with multidrug-resistant pseudomonas infection and renal insufficiency
    Stokem, Katie
    Zuckerman, Jonathan B.
    Nicolau, David P.
    Wungwattana, Minkey
    Sears, Edmund H.
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 23 : 8 - 9
  • [38] Failure of ceftolozane-tazobactam salvage therapy in complicated pneumonia with lung abscess
    Lewis, Paul O.
    Cluck, David B.
    Tharp, Jennifer L.
    Krolikowski, Matthew A.
    Patel, Paras D.
    CLINICAL CASE REPORTS, 2018, 6 (07): : 1308 - 1312
  • [39] Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model
    VanScoy, Brian
    Mendes, Rodrigo E.
    Castanheira, Mariana
    McCauley, Jennifer
    Bhavnani, Sujata M.
    Forrest, Alan
    Jones, Ronald N.
    Okusanya, Olanrewaju O.
    Friedrich, Lawrence V.
    Steenbergen, Judith
    Ambrose, Paul G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (09) : 4134 - 4138
  • [40] Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
    Oliver, Wesley D.
    Heil, Emily L.
    Gonzales, Jeffrey P.
    Mehrotra, Shailly
    Robinett, Kathryn
    Saleeb, Paul
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1899 - 1901
12345